No / Whereas protease inhibitors have been developed successfully against hypertension and viral infections, they have failed thus far as cancer drugs. With advances in cancer profiling we now better understand that the tumor “degradome” (i.e. the repertoire of proteases and their natural inhibitors and interaction partners) forms a complex network in which specific nodes determine the global outcome of manipulation of the protease web. However, knowing which proteases are active in the tumor micro-environment, we may tackle cancers with the use of Protease-Activated Prodrugs (PAPs). Here we exemplify this concept for metallo-, cysteine and serine proteases. PAPs not only exist as small molecular adducts, containing a cleavable substrate sequence and a latent prodrug, they are presently also manufactured as various types of nanoparticles. Although the emphasis of this review is on PAPs for treatment, it is clear that protease activatable probes and nanoparticles are also powerful tools for imaging purposes, including tumor diagnosis and staging, as well as visualization of tumor imaging during microsurgical resections.

Modulation of the tumor microenvironment represents a possible way to inhibit cancer growth and enhance anti-cancer immune responses. In the presented work we employ two strategies for tumor microenvironment modulation. Firstly, we have constructed rVACV co-expressing the tumor suppressor gene insulin-like growth factor-binding protein-3 (IGFBP- 3) and the fusion gene encoding the immunogen SigE7LAMP. The expression of IGFBP-3 was regulated either by the early vaccinia virus H5 promoter or by the synthetic early/late (E/L) promoter. We have shown that expression of IGFBP-3 regulated by the H5 promoter yielded higher amounts of IGFBP-3 protein when compared with the E/L promoter. Immunization with P13-SigE7LAMP-H5-IGFBP-3 was more effective in inhibiting the growth of TC-1 tumors in mice and elicited a higher T-cell response against VACV-encoded antigens than the control virus P13-SigE7LAMP-TK- . We found that high-level production of IGFBP-3 enhanced virus replication both in vitro and in vivo, resulting in profound antigen stimulation. Production of IGFBP-3 was associated with a higher adsorption rate of P13-SigE7LAMP-H5-IGFBP-3 to CV-1 cells when compared with P13-SigE7LAMP-TK- . We have identified two structural differences between the IMVs of the IGFBP-3 expressing virus P13-SigE7LAMP-H5-IGFBP-3...

Cysteine proteases are important drug targets due to their involvement in many biological processes such as protein turnover, digestion, blood coagulation, apoptosis, cell differentiation, cell signaling, and the immune response. In this thesis, we have reported the design, synthesis and evaluation of clan CA and clan CD cysteine protease inhibitors. Aza-peptidyl Michael acceptor and epoxide inhibitors for asparaginyl endopeptidases (legumains) from the bloodfluke, Schistosoma mansoni (SmAE) and the hard tick, Ixodes ricinus (IrAE) were designed and synthesized. SARs were similar, but with some notable exceptions. Both enzymes prefer disubstituted amides to monosubstituted amides in the P1' position and potency increased as we increased the hydrophobicity of the inhibitor in this position. Extending the inhibitor to P5 resulted in increased inhibitory potency, especially against IrAE, and both enzymes prefer small over large hydrophobic residues in the P2 position. Aza-peptide Michael acceptor inhibitors are more potent than aza-peptide epoxide inhibitors and, for some of these compounds, second order inhibition rate constants are the fastest yet discovered. We have also synthesized aza-peptidyl Michael acceptor and epoxide inhibitors for the parasitic cysteine proteases; cruzain, rhodesain. We have found that monosubstituted amides were favored over disubstituted amides indicating the involvement of the amide hydrogen in a H-bond network. We have shown that aza-peptide epoxides were as potent as Michael acceptors and we have obtained compounds with IC50 values as low as 20 nM. We have worked on the synthesis of heterocyclic peptidyl α-ketoamides, peptidyl ketones and aza-peptidyl ketones as calpain inhibitors. We have synthesized peptidyl α-ketoamides with nucleotide bases in the primed region to create compounds that can cross the blood-brain barrier. We have improved the potency by introducing a hydrophobic group on the adenine ring. We have obtained compounds with Ki values in the nanomolar range. We have designed peptidyl aminoketones as a new class of inhibitors for calpain. Peptidyl aminoketones were less potent than peptidyl α-ketoamides but still reasonable inhibitors of calpain that have the potential to cross the BBB.

Made available in DSpace on 2016-06-02T20:21:36Z (GMT). No. of bitstreams: 1 6407.pdf: 1899401 bytes, checksum: d7929c149990e2a77bfc5e204bc566f5 (MD5) Previous issue date: 2014-09-04 / Universidade Federal de Minas Gerais / Cysteine proteases (CPs) are proteolytic enzymes which have a cysteine residue at its active site. Plant legumains are CPs known as vacuolar processing enzymes and they play key roles in seed maturation, germination, senescence, stress response, programmed cell death during development and defense against pathogens. Although there are many studies about plant legumains, most of them is related to legumain functions in seeds of dicotyledonous. To date, only one legumain from sugarcane has been described. In this study, it was performed the characterization of a new sugarcane legumain, named CaneLEG2. The recombinant CaneLEG2 was produced in the heterologous expression system Pichia pastoris and its kinetic characterization showed that it exhibits self-activation and activity under acidic pH, which are common features of plant legumains. This study also demonstrated that the sugarcane cystatin CaneCPI-3 has a strong inhibition over the CaneLEG2 activity, suggesting that this cystatin may participate of the regulation of endogenous cysteine proteases. The results obtained in this work will support the understanding of the functions of CaneLEG2 and CaneCPI-3 in sugarcane. / As cisteino-peptidases (CPs) são enzimas proteoliticas que possuem um resíduo de cisteina em seu sitio ativo. As legumainas de plantas são CPs conhecidas como enzimas de processamento vacuolar (VPE) e participam nos processos de maturação de sementes, germinação, senescência, resposta a estresses, morte celular programada no desenvolvimento da planta ou em resposta ao ataque de patógenos. Embora existam diversos estudos com legumainas de plantas, a maioria deles esta relacionada as funções das legumainas em sementes de dicotiledoneas. Ate o momento, apenas uma legumaina de cana-de-açúcar havia sido descrita. Neste presente trabalho, foi realizada a caracterização de uma nova legumaina de cana-de-açúcar, denominada CaneLEG2. A CaneLEG2 recombinante foi produzida em sistema de expressão heterologa Pichia pastoris e sua caracterização cinetica mostrou que ela apresenta auto-ativação e atividade em pH ácido, caracteristicas comuns em legumainas de plantas. Esse estudo ainda demonstrou que a cistatina de cana-de-açúcar CaneCPI-3 exerce uma forte inibição sobre a atividade da CaneLEG2, sugerindo que essa cistatina pode atuar na regulação de cisteino-peptidases endógenas. Os resultados obtidos neste trabalho ajudam no entendimento das funções exercidas pela CaneLEG2 e CaneCPI-3 na cana-de-açúcar.

The intracellular proteolysis of ingested meal plays an essential role in tick development. The thesis focuses on the factors influencing the expressions and activities of digestive enzymes in Ixodes ricinus females during the feeding and post-feeding period. We have revealed the effect of fertilization on blood feeding and digestion. The females cannot reach the rapid engorgement phase without being fertilized. The rate of mated females in the nature proved the presumption that mating can occur even off the host. Implementation of in vitro feeding technique further extended our current knowledge about tick digestive apparatus. Adult females were fed on hemoglobin-rich and hemoglobin-poor diet and the mRNA expression levels of digestive proteases were determined. In line with obtained data, we assumed that albuminolysis is conducted by the same or similar pathway as hemoglobinolysis. The gene silencing method and protein immuno-detection were used to unequivocally identify the isoforms of 'early expressed' IrCL1 and 'late expressed' IrCL3 isoform of cathepsin L.